Logo

Home

smallArrow

Stocks Screener

smallArrow

Nectar Lifesciences

Nectar Lifesciences Share Price

Nectar Lifesciences (INR)51.49-0.2   (-0.3%)

Exchange ScripsBSE532649NSENECLIFEISININE023H01027

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Nectar Lifesciences Performance

Market performance
Open price51.94
High53.4
Volumes7733869
Prev Close51.49
Low48.98
Closing date2024-09-09
Historical performance
1 Year High53.80
3 Year High53.80
5 Year High53.80
1 Year Low21.50
3 Year Low14.50
5 Year Low7.10

Nectar Lifesciences Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
741
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
231.21
Dividend Yield
Dividend Yield
N/A

Nectar Lifesciences Investment Returns

1 Year
89.3%
3 Years
74.2%
5 Years
255.1%
10 Years
26%

Nectar Lifesciences Technicals

IndicatorsValueSignal
5-DMA45.74Bullish
10-DMA42.82Bullish
20-DMA38.2Bullish
50-DMA33.53Bullish
100-DMA33.37Bullish
200-DMA33.64Bullish

Shareholding Pattern

FieldJun-2024Mar-2024Dec-2023Sep-2023Jun-2023
Promoters22222
Foreign Investors---------------
Domestic Investors22222
Public Investors5822759943607586028061579
Government11111

Nectar Lifesciences Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income243531113114
Operating Profit1759106116991128
Interest9698947881120
Depreciation607591570603
Profit Before Tax183-424341-848
Consolidated Net Profit50-242250-733
Adjusted EPS----11-3

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital224224224224
Total Reserves10468104221065510396
Minority Interest------------
Total Non-Current Liabilities1415213129631264
Total Liabilities21836216862388023758
Capital Work in Progress658778851986
Total Assets21836216862388023758

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities22471337950214
Cash Flow from Investing Activities-170517166-286
Cash Flow from Financing Activitie-2054-1856-1194115
Net Cash Inflow / Outflow22-2-7742
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 231.21.
  • 3Y Stock Price CAGR of the stock is 21.0.
  • The stock has a beta of 1.0.
  • In the last financial year, the company had an EBITDA of ₹1759 Million.
  • The company generated revenue of ₹16841 Million in the previous financial year.

Nectar Lifesciences

51.49-0.2   (-0.3%)

Investment Amount: ₹ 2640
Current Value: ₹ 5149
Performence: 95%
P/L: ₹ 2509
Top Gainers
SymbolChange%
DEEPINDS476.6(20%)
CLEDUCATE123.04(19%)
TBZ270.37(16%)
SYNCOMF26.77(16%)
MOTISONS219.85(12%)
Top Losers
SymbolChange%
RAMASTEEL14.86(-10%)
LAXMICOT37.48(-10%)
VSTIND439.55(-9%)
NDLVENTURE105.28(-8%)
JWL508.5(-7%)
AHL510.5(-7%)
ALKALI124.3(-6%)
ASHAPURMIN291.8(-6%)
Similar stocks

Panacea Biotec

▲ 101.4

270.51

August 10 - September 10

Syncom Formulations

▲ 72.9

26.77

August 10 - September 10

Morepen Laboratories

▲ 61.7

94.03

August 10 - September 10

SMS Lifesciences

▲ 54.4

1749.65

August 10 - September 10

Supriya Lifescience

▲ 35.2

608.3

August 10 - September 10

Vimta Labs

▲ 34.4

675.15

August 10 - September 10

Caplin Point Lab

▲ 34

2010.15

August 10 - September 10

Marksans Pharma

▲ 32.5

258.37

August 10 - September 10

Announcing Stock of the Month!

 

Phone

Registered Users

10 lacs

Google Rating

4.6